Close Menu

NEW YORK – PerkinElmer said after the close of the market on Tuesday that its second quarter revenues grew 12 percent year over year as Diagnostics segment revenues were up 46 percent.

For the three months ended July 5, the company reported total revenues of $811.7 million compared to $722.5 million a year ago. It beat the consensus Wall Street estimate of $726.4 million.

Organically, revenues rose 13 percent year over year, PerkinElmer CFO Jamey Mock said on a conference call following the release of the financial results.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.